The IBRCAF 2023 is a premier international scientific forum focused on hereditary cancer, bringing together leading researchers, clinicians, and industry professionals to share knowledge, foster collaboration, and drive innovation towards improved patient outcomes.
Headquarters:
Singapore
Company Type:
SME
Company size:
11-50 Employees
Address:
null
LOW
spending power